Chief Executive Officer
Paloma Pharmaceuticals, Inc
37 Neillian Crescent
Jamaica Plain, MA 02130
(617) 407-6314 voice and fax
dsherris@sherrispharma.com
www.sherrispharma.com
Dr. Sherris has over 21 years of experience in the biopharmaceutical and diagnostics
world. Presently, Dr. Sherris is CEO and founder of a consulting/out-sourcing
concern, Sherris Pharma Partners, working with blue chip clients for business
development and R&D strategy, with a niche focus in angiogenesis and vascular
targeting. In addition to business development and R&D work, Dr. Sherris
has worked with venture capital companies where he has both advised and raised
seed money for biotech startups. Prior to his starting Sherris Pharma Partners,
Dr. Sherris had been employed by pharmaceutical and biotechnology companies
to manage external R&D (academic groups and contract research organizations)
to augment and expand internal scientific programs.
Dr. Sherris has been a frequent invited guest speaker at biopharmaceutical
business and scientific conferences, a well-published author and holder of patents
in a wide range of therapeutic areas. Dr. Sherris has held positions of increasing
responsibility at Centocor, Unilever Research, Serono and OXiGENE where he was
Chief Operating Officer and Vice President of Research and Development, as well
as Chief Operating Officer of a joint venture between OXiGENE and Peregrine
Pharmaceuticals, Arcus LLC. Dr. Sherris received his Ph.D. in Biochemistry from
the University of Utah, held a postdoctoral position in immunology at the Jackson
Laboratory and a faculty position in the Department of Medicine, Division of
Clinical Immunology at the Mt. Sinai Medical Center, New York, NY.
|